loader
Please Wait
Applying Filters...

Ofichem Header Ofichem Header

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Technical details about Samuraciclib, learn more about the structure, uses, toxicity, action, side effects and more

    Client Email Product
    Menu

    Samuraciclib

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass

    Rochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    2D Structure
    1. Also known as: Icec0942, Ct7001, Icec-0942, 1805833-75-3, Icec0942 free base, Ct-7001
    Molecular Formula
    C22H30N6O
    Molecular Weight
    394.5  g/mol
    InChI Key
    YCVGLKWJKIKVBI-MJGOQNOKSA-N
    FDA UNII
    46D4HS9ODA
    Samuraciclib is an orally available, selective inhibitor of cyclin-dependent kinase 7 (CDK7) with potential antineoplastic activity. Upon oral administration, samuraciclib selectively and competitively binds to the CDK7 ATP binding site, thereby inhibiting CDK7-mediated signaling. CDK7, a serine/threonine kinase, plays a role in controlling cell cycle progression, transcriptional regulation, and promotes the expression of key oncogenes such as c-Myc through the phosphorylation of RNA polymerase II. Inhibition of CDK7 may inhibit tumor cell proliferation in certain cancers that are dependent on CDK7-mediated transcriptional regulation and signaling.
    1 2D Structure

    2D Structure

    2 Identification
    2.1 Computed Descriptors
    2.1.1 IUPAC Name
    (3R,4R)-4-[[[7-(benzylamino)-3-propan-2-ylpyrazolo[1,5-a]pyrimidin-5-yl]amino]methyl]piperidin-3-ol
    2.1.2 InChI
    InChI=1S/C22H30N6O/c1-15(2)18-13-26-28-21(25-11-16-6-4-3-5-7-16)10-20(27-22(18)28)24-12-17-8-9-23-14-19(17)29/h3-7,10,13,15,17,19,23,25,29H,8-9,11-12,14H2,1-2H3,(H,24,27)/t17-,19+/m1/s1
    2.1.3 InChI Key
    YCVGLKWJKIKVBI-MJGOQNOKSA-N
    2.1.4 Canonical SMILES
    CC(C)C1=C2N=C(C=C(N2N=C1)NCC3=CC=CC=C3)NCC4CCNCC4O
    2.1.5 Isomeric SMILES
    CC(C)C1=C2N=C(C=C(N2N=C1)NCC3=CC=CC=C3)NC[C@H]4CCNC[C@@H]4O
    2.2 Other Identifiers
    2.2.1 UNII
    46D4HS9ODA
    2.3 Synonyms
    2.3.1 Depositor-Supplied Synonyms

    1. Icec0942

    2. Ct7001

    3. Icec-0942

    4. 1805833-75-3

    5. Icec0942 Free Base

    6. Ct-7001

    7. 46d4hs9oda

    8. 1805833-75-3 (free Base)

    9. Samuraciclib Hcl

    10. (3~{r},4~{r})-4-[[[7-(benzylamino)-3-propan-2-ylpyrazolo[1,5-a]pyrimidin-5-yl]amino]methyl]piperidin-3-ol

    11. (3r,4r)-4-[[[7-(benzylamino)-3-propan-2-ylpyrazolo[1,5-a]pyrimidin-5-yl]amino]methyl]piperidin-3-ol

    12. 3-piperidinol, 4-(((3-(1-methylethyl)-7-((phenylmethyl)amino)pyrazolo(1,5-a)pyrimidin-5-yl)amino)methyl)-, (3r,4r)-

    13. (3r,4r)-4-[[[7-[(phenylmethyl)amino]-3-propan-2-yl-pyrazolo[1,5-a]pyrimidin-5-yl]amino]methyl]piperidin-3-ol

    14. 3-piperidinol, 4-[[[3-(1-methylethyl)-7-[(phenylmethyl)amino]pyrazolo[1,5-a]pyrimidin-5-yl]amino]methyl]-, (3r,4r)-

    15. Samuraciclib Di-hcl

    16. Ct7001 Di-hcl

    17. Samuraciclib [inn]

    18. Unii-46d4hs9oda

    19. Ct-7001 Di-hcl

    20. Ct7001 Hcl

    21. Samuraciclib [who-dd]

    22. Ct-7001 Hcl

    23. Gtpl9903

    24. Ppda-001

    25. Chembl4297488

    26. Schembl17032274

    27. Ex-a3445

    28. Bdbm50526797

    29. Mfcd32638713

    30. Nsc832261

    31. Nsc835588

    32. Nsc-832261

    33. Nsc-835588

    34. Hy-103712

    35. (3r,4r)-4-(((7-(benzylamino)-3-isopropylpyrazolo[1,5-a]pyrimidin-5-yl)amino)methyl)piperidin-3-ol

    36. (3r,4r)-4-((7-(benzylamino)-3-isopropylpyrazolo[1,5-a]pyrimidin-5-ylamino)methyl)piperidin-3-ol Dihydrochloride

    37. (3r,4r)-4-({[7-(benzylamino)-3-(propan-2-yl)pyrazolo[1,5-a]pyrimidin-5-yl]amino}methyl)piperidin-3-ol

    38. 3-piperidinol,4-[[[3-(1-methylethyl)-7-[(phenylmethyl)amino]pyrazolo[1,5-a]pyrimidin-5-yl]amino]methyl]-,(3r,4r)-

    2.4 Create Date
    2015-09-08
    3 Chemical and Physical Properties
    Molecular Weight 394.5 g/mol
    Molecular Formula C22H30N6O
    XLogP32.9
    Hydrogen Bond Donor Count4
    Hydrogen Bond Acceptor Count6
    Rotatable Bond Count7
    Exact Mass394.24810960 g/mol
    Monoisotopic Mass394.24810960 g/mol
    Topological Polar Surface Area86.5 Ų
    Heavy Atom Count29
    Formal Charge0
    Complexity500
    Isotope Atom Count0
    Defined Atom Stereocenter Count2
    Undefined Atom Stereocenter Count0
    Defined Bond Stereocenter Count0
    Undefined Bond Stereocenter Count0
    Covalently Bonded Unit Count1
    Post Enquiry
    POST ENQUIRY